|
Market Closed -
Bombay S.E.
05:02:29 2026-11-11 am EST
|
5-day change | 1st Jan Change | ||
| 506.45 INR | -0.33% |
|
+0.42% | +14.75% |
| Market Cap | 35.66B 380M 343M 317M 286M 541M 555M 3.79B 1.51B 19.1B 1.43B 1.4B 60.77B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 37.76B 403M 363M 335M 303M 573M 588M 4.02B 1.6B 20.22B 1.51B 1.48B 64.36B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.71% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
| UNICHEMLAB | Delayed |
| 1 day | -0.33% | ||
| 1 week | +0.42% | ||
| Current month | +4.76% | ||
| 1 month | -4.37% | ||
| 3 months | -0.30% | ||
| 6 months | +31.51% | ||
| Current year | +14.75% |
| 1 week | 490.1 | 525.95 | |
| 1 month | 462 | 540.6 | |
| Current year | 280 | 685.95 | |
| 1 year | 280 | 685.95 | |
| 3 years | 280 | 949.85 | |
| 5 years | 197.5 | 949.85 | |
| 10 years | 75.1 | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2023-08-09 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 2024-08-07 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 1977-08-21 | |
Pranay Godha
BRD | Director/Board Member | 53 | 2023-08-09 |
| Director/Board Member | 57 | 2023-08-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.33% | +0.42% | +9.78% | +23.87% | 382M | ||
| -0.51% | +0.36% | +43.94% | +132.25% | 1,276B | ||
| -1.19% | +0.30% | +42.98% | +87.73% | 676B | ||
| -0.85% | -1.26% | +29.28% | +109.97% | 519B | ||
| +0.02% | +1.52% | +39.21% | +68.34% | 388B | ||
| -1.55% | -3.18% | +60.06% | +42.07% | 365B | ||
| -1.29% | -1.13% | +27.54% | +56.87% | 307B | ||
| +0.09% | -0.91% | +3.19% | +35.60% | 287B | ||
| -0.74% | -3.51% | +36.41% | +73.11% | 252B | ||
| -0.92% | -3.06% | +38.01% | +125.73% | 212B | ||
| Average | -0.76% | +2.18% | +33.04% | +75.55% | 428B | |
| Weighted average by Cap. | -0.79% | +2.51% | +38.31% | +93.35% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 225M 203M 187M 169M 321M 328M 2.25B 895M 11.31B 845M 827M 35.98B | 22.02B 235M 212M 195M 177M 334M 343M 2.34B 934M 11.79B 881M 862M 37.53B |
| Net income | 1.38B 14.66M 13.22M 12.21M 11.04M 20.88M 21.4M 146M 58.32M 737M 55.03M 53.86M 2.34B | 2.53B 26.96M 24.3M 22.45M 20.29M 38.39M 39.34M 269M 107M 1.35B 101M 99.02M 4.31B |
| Net Debt | 3.7B 39.47M 35.57M 32.87M 29.71M 56.21M 57.6M 394M 157M 1.98B 148M 145M 6.31B | 2.11B 22.46M 20.24M 18.7M 16.91M 31.99M 32.78M 224M 89.34M 1.13B 84.3M 82.51M 3.59B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | ₹506.45 | -0.33% | 3,870 |
| 26-11-09 | ₹508.15 | +1.07% | 4,382 |
| 26-11-08 | ₹502.75 | -0.04% | 759 |
| 26-11-06 | ₹502.95 | +1.89% | 4,497 |
| 26-11-05 | ₹493.60 | -2.07% | 3,548 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
















